Found: 10
Select item for more details and to access through your institution.
1556. Assessment of Translational In Vitro and Animal Pharmacokinetic–Pharmacodynamic Data Used to Support Drug Development of Recent Tetracycline Derivatives.
- Published in:
- Open Forum Infectious Diseases, 2019, v. 6, p. S568, doi. 10.1093/ofid/ofz360.1420
- By:
- Publication type:
- Article
Azithromycin and terfenadine: Lack of drug interaction<sup>*</sup>.
- Published in:
- Clinical Pharmacology & Therapeutics, 1995, v. 58, n. 3, p. 310, doi. 10.1016/0009-9236(95)90247-3
- By:
- Publication type:
- Article
Age and propranolol stereoselective disposition in humans.
- Published in:
- Clinical Pharmacology & Therapeutics, 1992, v. 51, n. 5, p. 489, doi. 10.1038/clpt.1992.52
- By:
- Publication type:
- Article
Age and β-adrenergic receptor sensitivity to S(−)- and R,S(±)-propranolol in humans.
- Published in:
- Clinical Pharmacology & Therapeutics, 1992, v. 51, n. 5, p. 549, doi. 10.1038/clpt.1992.61
- By:
- Publication type:
- Article
Regulatory Review Approach for Evaluation of Micafungin for Treatment of Neonatal Candidiasis.
- Published in:
- Clinical Infectious Diseases, 2021, v. 73, n. 12, p. 2335, doi. 10.1093/cid/ciab025
- By:
- Publication type:
- Article
Effect of Body Weight and Age on the Pharmacokinetics of Dihydroartemisinin: Food and Drug Administration Basis for Dose Determination of Artesunate for Injection in Pediatric Patients With Severe Malaria.
- Published in:
- Clinical Infectious Diseases, 2021, v. 73, n. 5, p. 903, doi. 10.1093/cid/ciab149
- By:
- Publication type:
- Article
The Hollow Fiber System Model in the Nonclinical Evaluation of Antituberculosis Drug Regimens.
- Published in:
- Clinical Infectious Diseases, 2015, v. 61, p. S32, doi. 10.1093/cid/civ460
- By:
- Publication type:
- Article
New Era in Drug Interaction Evaluation: US Food and Drug Administration Update on CYP Enzymes, Transporters, and the Guidance Process.
- Published in:
- Journal of Clinical Pharmacology, 2008, v. 48, n. 6, p. 662, doi. 10.1177/0091270007312153
- By:
- Publication type:
- Article
Food and Drug Administration Public Workshop Summary—Addressing Challenges in Inhaled Antifungal Drug Development.
- Published in:
- Clinical Infectious Diseases, 2024, v. 78, n. 6, p. 1564, doi. 10.1093/cid/ciad607
- By:
- Publication type:
- Article
Food and Drug Administration Public Workshop Summary—Development Considerations of Antifungal Drugs to Address Unmet Medical Need.
- Published in:
- Clinical Infectious Diseases, 2023, v. 77, n. 3, p. 380, doi. 10.1093/cid/ciad195
- By:
- Publication type:
- Article